Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus

Phase II Study of Pre-Operative Chemotherapy With Taxol, Cisplatin, and 5-Fluorouracil Followed by G-CSF in Patients With Resectable Local-Regional Carcinoma of Esophagus

Status

Terminated

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00208936

Enrollment

Registered

2005-09-21

Start date

1996-01-31

Completion date

Unknown

Last updated

2014-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Diseases

Keywords

Esophageal Diseases

Brief summary

This study is designed pre-operative for patients with resectable, local-regional carcinoma of the esophagus.

Detailed description

This study is designed for patients with resectable, local-regional carcinoma of the esophagus. In a pre-operative setting, chemotherapy with Taxol, Cisplatin, and 5-Fluorouracil will be administered followed by G-CSF.

Interventions

DRUGTaxol, Cisplatin, 5-Fluorouracil, G-CSF

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Measurable disease with resectable local-regional carcinoma of the esophagus. 18 years of age or older.

Exclusion criteria

* Pregnant or lactating. Non-resectable local-regional carcinoma of the esophagus.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026